Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "The trades are on the buy side, primarily midcaps which are doing well. Bharat Financial Inclusion which has come up from a bear market is having a V-shaped rally but since that rally is continuing, we will go long in it. Pidilite Industries is one of the rare consumer product companies that is doing well, most others are best avoided. But Pidilite is just breaking from a trading range, again a buying opportunity. Strides Shasun which has been a favourite pharma company for me, keep on buying it."
"UltraTech Cement at current level is an investment buying opportunity. Investment buyers should also be prepared for deep drawdown in between. The markets haven’t come out of the woods but cement is not my favourite sector for the near-term," he said.
"Pharma and IT are the two leading players on the stock markets for exports, both are suggesting that their corrections are getting over, they are building bases and they are giving us the first signs of life or green shoots. So pharma and IT are buying opportunities. These opportunities will remain if the Nifty remain steady. The Nifty doesn’t have to go up. These two sectors will outperform."